Latest atopic dermatitis Stories
U.S. researchers say they discovered powerful relief in the form of a diluted bleach bath for children who suffer flare-ups of the skin disorder eczema.
Launched at the 67th Annual American Academy of Dermatology Meeting CRANFORD, N.J., March 19 /PRNewswire/ -- Triax Pharmaceuticals, the marketers of Locoid Lipocream(R) (hydrocortisone butyrate 0.1%) the leading mid-potency corticosteroid brand, introduces a new 4 oz.
Test builds on company's suite of tests to evaluate immune function LENEXA, Kan., March 12 /PRNewswire/ -- IBT Laboratories, a leading clinical-diagnostics and biomedical-research laboratory specializing in immunology and allergy assays, will launch a new diagnostic assay designed to help physicians better understand and manage their patients who have recurrent infections.
TURKU, Finland, March 12 /PRNewswire/ -- BioCis Pharma Ltd., a privately-held drug development company with its headquarters in Turku, Finland, announced that it has begun a new Phase IIa clinical testing of ProtoCure(TM) emulsion cream, the company's novel topical drug for dermatology.
SAN FRANCISCO, March 5 /PRNewswire-USNewswire/ -- Atopic dermatitis, the common, chronic, inflammatory skin disease marked by red, itchy rashes, has been increasing in prevalence over the past two decades and affects a disproportionate number of children.
New Study in the Journal of Cosmetic Dermatology Finds Over-the-Counter (OTC) Albolene(R) Moisturizing Cleanser as Effective as a Prescription Moisturizer for Helping to Clear Up Mild to Moderate Eczema EDISON, N.J., March 5 /PRNewswire/ -- Mild to moderate eczema sufferers who are looking for a cost-effective way to control and heal this skin condition without a prescription now have a new option to consider.
A Once-Daily Topical Agent With a Novel Mechanism of Action and Efficacy Advantages Over Elidel Would Earn Higher Patient Share in the U.S. Than in Europe, According to a New Report from Decision Resources WALTHAM, Mass., Feb.
MEMPHIS, Tenn., Jan.
Research findings presented at the 2008 American College of Allergy, Asthma and Immunology (ACAAI) Scientific Meeting revealed a significant cost savings associated with allergy immunotherapy (IT) in children with allergic rhinitis (AR).
BioCis Pharma, a privately-held drug development company, has initiated Phase IIa clinical testing of ProtoCure emulsion cream, the company's novel topical drug for dermatology.
- A political dynamiter.